The Chronic Airways Assessment Test (CAAT™): Evolution From the COPD Assessment Test (CAT™).
作者信息
Tal-Singer Ruth, Chalmers James D, Jones Paul W, Reddel Helen K, Oga Toru, Vogelmeier Claus F, Yorke Janelle, Miller Bruce E
机构信息
Global Allergy and Airways Patient Platform, Vienna, Austria.
Division of Respiratory Medicine and Gastroenterology, University of Dundee, Dundee, United Kingdom.
出版信息
Chronic Obstr Pulm Dis. 2025 May 27;12(3):203-206. doi: 10.15326/jcopdf.2025.0614.
Abstract
摘要
相似文献
1
The Chronic Airways Assessment Test (CAAT™): Evolution From the COPD Assessment Test (CAT™).慢性气道评估测试（CAAT™）：从慢性阻塞性肺疾病评估测试（CAT™）演变而来。
Chronic Obstr Pulm Dis. 2025 May 27;12(3):203-206. doi: 10.15326/jcopdf.2025.0614.
2
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.慢性气道评估测试：在哮喘和/或 COPD 患者中的心理测量特性。
Respir Res. 2023 Apr 8;24(1):106. doi: 10.1186/s12931-023-02394-6.
3
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预：针对慢性阻塞性肺疾病（COPD）患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
4
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).干预措施以提高慢性阻塞性肺疾病（COPD）药物治疗的依从性。
Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2.
5
The COPD Assessment Test: What Do We Know So Far?: A Systematic Review and Meta-Analysis About Clinical Outcomes Prediction and Classification of Patients Into GOLD Stages.COPD 评估测试：目前我们了解多少？：一项关于临床结局预测和 GOLD 分期分类的系统评价和荟萃分析。
Chest. 2016 Feb;149(2):413-425. doi: 10.1378/chest.15-1752. Epub 2016 Jan 12.
6
Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease.对于慢性阻塞性肺疾病患者，每日一次长效β₂受体激动剂/吸入性糖皮质激素联合吸入器与吸入性长效毒蕈碱拮抗剂的比较
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012355. doi: 10.1002/14651858.CD012355.pub2.
7
Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study.自我管理问卷在日本识别 COPD 高危个体中的效用：OCEAN（冲绳 COPD 病例发现评估）研究。
Int J Chron Obstruct Pulmon Dis. 2021 Jun 17;16:1771-1782. doi: 10.2147/COPD.S302259. eCollection 2021.
8
Airway clearance techniques for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的气道廓清技术
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD008328. doi: 10.1002/14651858.CD008328.pub2.
9
Self-management interventions for people with chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病患者的自我管理干预措施。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.
10
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗：一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
本文引用的文献
1
Responsiveness and minimal clinically important difference of the COPD Assessment Test in fibrotic interstitial lung disease.COPD 评估测试在肺纤维化间质性肺疾病中的反应性和最小临床重要差异。
Respir Investig. 2024 Nov;62(6):1088-1093. doi: 10.1016/j.resinv.2024.08.006. Epub 2024 Sep 26.
2
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.有烟草暴露但肺功能正常的参与者的纵向随访。
JAMA. 2023 Aug 1;330(5):442-453. doi: 10.1001/jama.2023.11676.
3
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.慢性气道评估测试：在哮喘和/或 COPD 患者中的心理测量特性。
Respir Res. 2023 Apr 8;24(1):106. doi: 10.1186/s12931-023-02394-6.
4
The prognostic value of the COPD Assessment Test in fibrotic interstitial lung disease.COPD 评估测试在肺纤维化性间质性肺疾病中的预后价值。
Respir Investig. 2022 Jan;60(1):99-107. doi: 10.1016/j.resinv.2021.07.007. Epub 2021 Sep 20.
5
Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study.自我管理问卷在日本识别 COPD 高危个体中的效用：OCEAN（冲绳 COPD 病例发现评估）研究。
Int J Chron Obstruct Pulmon Dis. 2021 Jun 17;16:1771-1782. doi: 10.2147/COPD.S302259. eCollection 2021.
6
Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort.医生诊断的哮喘和/或慢性阻塞性肺疾病内部及之间的异质性：新型队列研究。
Eur Respir J. 2021 Sep 23;58(3). doi: 10.1183/13993003.03927-2020. Print 2021 Sep.
7
Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.慢性阻塞性肺疾病评估测试的临床开发与研究应用
Am J Respir Crit Care Med. 2020 May 1;201(9):1058-1067. doi: 10.1164/rccm.201907-1369PP.
8
Validation of the COPD Assessment Test (CAT) as an Outcome Measure in Bronchiectasis.支气管扩张症中 COPD 评估测试（CAT）作为结局指标的验证。
Chest. 2020 Apr;157(4):815-823. doi: 10.1016/j.chest.2019.10.030. Epub 2019 Nov 12.
9
COPD Assessment Test (CAT) is a Valid and Simple Tool to Measure the Impact of Bronchiectasis on Affected Patients.慢性阻塞性肺疾病评估测试（CAT）是一种有效且简便的工具，用于衡量支气管扩张对受影响患者的影响。
COPD. 2018 Oct;15(5):512-519. doi: 10.1080/15412555.2018.1540034. Epub 2018 Nov 23.
10
The COPD Foundation Pocket Consultant Guide.慢性阻塞性肺疾病基金会袖珍咨询指南
Chronic Obstr Pulm Dis. 2014 May 6;1(1):83-87. doi: 10.15326/jcopdf.1.1.2014.0124.
Zotero 插件